搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Enterobacter sp. Phosphate acyltransferase (plsX) CSB-YP394683EIZ
CSB-EP394683EIZ
CSB-BP394683EIZ
CSB-MP394683EIZ
CSB-EP394683EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. High frequency lysogenization protein HflD homolog (hflD) CSB-YP394684EIZ
CSB-EP394684EIZ
CSB-BP394684EIZ
CSB-MP394684EIZ
CSB-EP394684EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Selenide, water dikinase (selD) CSB-YP394685EIZ
CSB-EP394685EIZ
CSB-BP394685EIZ
CSB-MP394685EIZ
CSB-EP394685EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP394686EIZ
CSB-EP394686EIZ
CSB-BP394686EIZ
CSB-MP394686EIZ
CSB-EP394686EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Multidrug resistance protein MdtK (mdtK), partial CSB-YP394687EIZ
CSB-EP394687EIZ
CSB-BP394687EIZ
CSB-MP394687EIZ
CSB-EP394687EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. UPF0060 membrane protein Ent638_1931 (Ent638_1931), partial CSB-YP394688EIZ1
CSB-EP394688EIZ1
CSB-BP394688EIZ1
CSB-MP394688EIZ1
CSB-EP394688EIZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Tautomerase pptA (pptA) CSB-YP394689EIZ
CSB-EP394689EIZ
CSB-BP394689EIZ
CSB-MP394689EIZ
CSB-EP394689EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. UPF0509 protein Ent638_2183 (Ent638_2183) CSB-YP394690EIZ
CSB-EP394690EIZ
CSB-BP394690EIZ
CSB-MP394690EIZ
CSB-EP394690EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. UPF0225 protein Ent638_2310 (Ent638_2310) CSB-YP394691EIZ
CSB-EP394691EIZ
CSB-BP394691EIZ
CSB-MP394691EIZ
CSB-EP394691EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Outer-membrane lipoprotein lolB (lolB) CSB-YP394692EIZ
CSB-EP394692EIZ
CSB-BP394692EIZ
CSB-MP394692EIZ
CSB-EP394692EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Cell division topological specificity factor (minE) CSB-YP394693EIZ
CSB-EP394693EIZ
CSB-BP394693EIZ
CSB-MP394693EIZ
CSB-EP394693EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Protease HtpX (htpX), partial CSB-YP394694EIZ1
CSB-EP394694EIZ1
CSB-BP394694EIZ1
CSB-MP394694EIZ1
CSB-EP394694EIZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. tRNA (mo5U34)-methyltransferase CSB-YP394695EIZ
CSB-EP394695EIZ
CSB-BP394695EIZ
CSB-MP394695EIZ
CSB-EP394695EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Alpha,alpha-trehalose-phosphate synthase [UDP-forming] (otsA) CSB-YP394696EIZ
CSB-EP394696EIZ
CSB-BP394696EIZ
CSB-MP394696EIZ
CSB-EP394696EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. ATP phosphoribosyltransferase (hisG) CSB-YP394697EIZ
CSB-EP394697EIZ
CSB-BP394697EIZ
CSB-MP394697EIZ
CSB-EP394697EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Multidrug resistance protein MdtA (mdtA) CSB-YP394698EIZ
CSB-EP394698EIZ
CSB-BP394698EIZ
CSB-MP394698EIZ
CSB-EP394698EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. UPF0299 membrane protein Ent638_2744 (Ent638_2744), partial CSB-YP394699EIZ1
CSB-EP394699EIZ1
CSB-BP394699EIZ1
CSB-MP394699EIZ1
CSB-EP394699EIZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (menH) CSB-YP394700EIZ
CSB-EP394700EIZ
CSB-BP394700EIZ
CSB-MP394700EIZ
CSB-EP394700EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP394701EIZ
CSB-EP394701EIZ
CSB-BP394701EIZ
CSB-MP394701EIZ
CSB-EP394701EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter sp. Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP394702EIZ
CSB-EP394702EIZ
CSB-BP394702EIZ
CSB-MP394702EIZ
CSB-EP394702EIZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>